Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

Gefitinib single drug in treatment of advanced esophageal cancer

Xu Yingjun, Xie Zhihui, Shi Yan, Zhang Mengwei, Pan Jia, Li Yanming, Lu Hong

Year : 2016| Volume: 12| Issue : 8 | Page no: 295-297

   This article has been cited by
 
1 Identification of Molecular Subtypes and Potential Small-Molecule Drugs for Esophagus Cancer Treatment Based on m6A Regulators
Jianjun Li, Hongbo Zhu, Qiao Yang, Hua Xiao, Haibiao Wu, Zhe Fang, Wenjun Li, Manbo Cai, Fu Wang
Journal of Oncology. 2022; 2022: 1
[Pubmed]  [Google Scholar] [DOI]
2 Machine Learning for Future Subtyping of the Tumor Microenvironment of Gastro-Esophageal Adenocarcinomas
Sebastian Klein, Dan G. Duda
Cancers. 2021; 13(19): 4919
[Pubmed]  [Google Scholar] [DOI]
3 Rapamycin suppresses the PI3K/AKT/mTOR signaling pathway by targeting SIRT1 in esophageal cancer
Tao Liu, Xiangsen Liang, Yu Sun, Shengzhuang Yang
Experimental and Therapeutic Medicine. 2021; 22(4)
[Pubmed]  [Google Scholar] [DOI]

 

Read this article